BamSEC and AlphaSense Join Forces
Learn More

Repare Therapeutics Inc.

NASDAQ: RPTX    
Share price (3/25/25): $1.03    
Market cap (3/25/25): $43.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 38 pages Repare Therapeutics Inc. Common Shares Sales Agreement
12/34/56
EX-10.1
from 10-Q 4 pages First Amendment to Lease
12/34/56
EX-10.1
from 10-Q 3 pages [***] Certain Schedules and Exhibits to This Exhibit Have Been Omitted Pursuant to Item 601(a)(5) of Regulation Sk. a Copy of Any Omitted Schedule and/or Exhibit Will Be Furnished to the SEC Upon Request. Fifth Amendment to Collaboration and License Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Amendment to Employment Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Fourth Amendmentto Collaboration and Licenseagreement
12/34/56
EX-10
from 10-Q 3 pages [***] Certain Schedules and Exhibits to This Exhibit Have Been Omitted Pursuant to Item 601(a)(5) of Regulation S-K. a Copy of Any Omitted Schedule and/or Exhibit Will Be Furnished to the SEC Upon Request. Lease Amendment Agreement No 1 Dated Effective April 1, 2023
12/34/56
EX-10
from 10-K 4 pages [***] Certain Information in This Document Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) Customarily and Actually Treated by the Registrant as Private or Confidential. Second Amendment to Research Services, License and Collaboration Agreement
12/34/56
EX-10
from 10-K 41 pages Agreement of Lease
12/34/56
EX-10
from 10-K 4 pages Lease Amending Agreement
12/34/56
EX-10.2
from 10-Q 3 pages [***] Certain Information in This Document Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) Customarily and Actually Treated by the Registrant as Private or Confidential. Second Amendment to Collaboration and License Agreement
12/34/56
EX-10.1
from 10-Q 3 pages [***] Certain Information in This Document Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) Customarily and Actually Treated by the Registrant as Private or Confidential. First Amendment to Collaboration and License Agreement
12/34/56
EX-10.2
from 10-Q 38 pages Repare Therapeutics Inc. Common Shares Sales Agreement
12/34/56
EX-10.1
from 10-Q 122 pages [***] Certain Information in This Document Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) Customarily and Actually Treated by the Registrant as Private or Confidential. Collaboration and License Agreement by and Between Repare Therapeutics Inc. and Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Lt
12/34/56
EX-10.28
from 10-K 2 pages Commencement Date Memorandum
12/34/56
EX-10.27
from 10-K 4 pages Fifth (5th) Amendment to Lease Agreement This Fifth Amendment to Lease Agreement Made This January-17-2022 Between: The Manufacturers Life Insurance Company (Hereinafter Called the "Landlord") of the First Part, and Repare Therapeutics Inc. (Hereinafter Called the "Tenant") of the Second Part,
12/34/56
EX-10.11
from 10-K 16 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 4 pages First Amendment to Research Services, License and Collaboration Agreement
12/34/56
EX-10.4
from 10-Q 46 pages Lease Rreef America REIT II Corp. Ppp, Landlord, and Repare Therapeutics USA Inc., Tenant Riverfront Office Park Cambridge, Massachusetts
12/34/56
EX-10.3
from 10-Q 8 pages Fourth (4th) Amendment to Lease Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Lease Amendment Agreement Dated Effective June 1, 2021. by and Between : Neomed Institute, a Corporation Governed by the Canada Not-For-Profit Corporations Act, Having Its Principal Place of Business at 7171, Frederick-Banting Street, Saint-Laurent, Province of Québec, H4s 1z9;
12/34/56